GAMMA Investing LLC Purchases 92,994 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

GAMMA Investing LLC boosted its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 1,462.9% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 99,351 shares of the medical instruments supplier's stock after purchasing an additional 92,994 shares during the quarter. GAMMA Investing LLC's holdings in DENTSPLY SIRONA were worth $1,484,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. Colonial Trust Co SC bought a new position in DENTSPLY SIRONA in the fourth quarter worth $26,000. Riverview Trust Co bought a new position in DENTSPLY SIRONA in the fourth quarter worth $26,000. Mitsubishi UFJ Asset Management Co. Ltd. raised its holdings in DENTSPLY SIRONA by 700.0% in the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,792 shares of the medical instruments supplier's stock worth $33,000 after purchasing an additional 1,568 shares in the last quarter. True Wealth Design LLC raised its holdings in DENTSPLY SIRONA by 866.7% in the fourth quarter. True Wealth Design LLC now owns 2,175 shares of the medical instruments supplier's stock worth $41,000 after purchasing an additional 1,950 shares in the last quarter. Finally, Quarry LP raised its holdings in DENTSPLY SIRONA by 25.7% in the fourth quarter. Quarry LP now owns 3,816 shares of the medical instruments supplier's stock worth $72,000 after purchasing an additional 780 shares in the last quarter. Institutional investors own 95.70% of the company's stock.

DENTSPLY SIRONA Stock Performance

NASDAQ XRAY traded up $0.03 during trading hours on Wednesday, hitting $15.40. The company's stock had a trading volume of 1,678,916 shares, compared to its average volume of 2,966,263. DENTSPLY SIRONA Inc. has a 12 month low of $12.16 and a 12 month high of $27.95. The company's 50 day simple moving average is $14.98 and its two-hundred day simple moving average is $16.78. The company has a market cap of $3.07 billion, a P/E ratio of -3.39, a price-to-earnings-growth ratio of 1.10 and a beta of 0.95. The company has a debt-to-equity ratio of 0.79, a current ratio of 1.10 and a quick ratio of 0.76.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last released its quarterly earnings data on Thursday, May 8th. The medical instruments supplier reported $0.43 EPS for the quarter, topping the consensus estimate of $0.29 by $0.14. DENTSPLY SIRONA had a positive return on equity of 14.31% and a negative net margin of 24.42%. The company had revenue of $879.00 million during the quarter, compared to the consensus estimate of $854.75 million. During the same period last year, the company earned $0.42 EPS. DENTSPLY SIRONA's revenue for the quarter was down 7.8% on a year-over-year basis. As a group, sell-side analysts expect that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 11th. Investors of record on Friday, June 27th will be issued a $0.16 dividend. The ex-dividend date of this dividend is Friday, June 27th. This represents a $0.64 annualized dividend and a yield of 4.16%. DENTSPLY SIRONA's payout ratio is -14.10%.

Analyst Ratings Changes

A number of equities analysts have issued reports on XRAY shares. UBS Group decreased their price objective on DENTSPLY SIRONA from $27.00 to $25.00 and set a "buy" rating for the company in a report on Friday, May 9th. Robert W. Baird cut their target price on DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating on the stock in a research note on Friday, February 28th. Wall Street Zen raised DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a research note on Friday, May 9th. Morgan Stanley cut DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 target price on the stock. in a research note on Tuesday, April 15th. Finally, Barrington Research increased their target price on DENTSPLY SIRONA from $20.00 to $21.00 and gave the stock an "outperform" rating in a research note on Monday, May 12th. Eleven analysts have rated the stock with a hold rating and three have issued a buy rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Hold" and a consensus target price of $20.36.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.